Levi & Korsinsky's Alert to Walgreens Investors Regarding Class Action
Levi & Korsinsky, LLP has issued an important notice for shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). This notification concerns a significant class action securities lawsuit aimed at addressing potential losses that investors may have incurred due to alleged fraudulent activities within the company. If you are an investor in Walgreens, it's essential to understand the details surrounding this case.
Understanding the Class Action Lawsuit
CLASS DEFINITION: This class action lawsuit is designed to help investors recover financial losses resulting from the alleged securities fraud that took place between October 12, 2023 and June 26, 2024. The lawsuit focuses on those who have been negatively affected by these fraudulent actions. For more information or to discuss your eligibility, interested individuals are encouraged to contact the legal team.
How to Get Involved
If you believe you have been impacted, be sure to follow the link provided for more information on how to submit your participation request:
https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form?prid=99044&wire=4
Get in Touch with Legal Experts
Investors can also reach out to Joseph E. Levi, Esq. via email at [email protected] or by calling (212) 363-7500 for additional assistance.
What Happened with Walgreens?
CASE DETAILS: The lawsuit arises from an announcement made by Walgreens on June 27, 2024. The company disclosed disappointing financial results for the third quarter of 2024, which led to a significant downgrade in their revenue forecasts for the rest of the fiscal year. This negative outlook was attributed to ongoing challenges in the U.S. Retail Pharmacy sector, exacerbated by an unexpectedly difficult consumer environment. Following this shocking news, Walgreens' stock price dropped by more than 20%, a significant decline from its previous closing price of $15.65 per share.
Important Next Steps for Investors
If you have experienced losses during this timeframe, it is crucial to take action promptly. You have until September 10, 2024 to file a petition with the Court to be recognized as a lead plaintiff. It’s important to understand that even if you do not take on this role, you may still have the right to benefit from any potential recovery.
No Financial Risks Involved
Joining this class action comes at no financial cost to class members. Those who qualify may receive compensation without incurring any expenses. There are no hidden fees or obligations tied to participation.
Why Choose Levi & Korsinsky?
Levi & Korsinsky boasts a strong track record that spans over two decades, successfully securing substantial compensation for affected shareholders in a variety of complex securities cases. Their dedicated team, comprising over 70 professionals, is committed to advocating for the interests of investors. They have consistently been recognized as one of the leading securities litigation firms in the country, as noted in the ISS Securities Class Action Services' Top 50 Report for several years running.
Contact Information
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
Frequently Asked Questions
What is the purpose of the class action lawsuit?
The lawsuit aims to recover losses for Walgreens investors who were affected by the alleged securities fraud during the specified period.
Who can participate in the lawsuit?
Any investor who suffered losses in Walgreens shares during the relevant timeframe is eligible to participate.
What steps do I need to take to be involved?
Investors should follow the provided link or contact the legal team to request participation as a lead plaintiff before the deadline.
Will it cost me anything to participate?
No, there are no costs or fees for class members to participate in the lawsuit.
Why should I choose Levi & Korsinsky?
Levi & Korsinsky has a proven history of successfully representing investors and possesses extensive experience in securities litigation.
